Evidence map›Paper›PMID 41935187›Full record

ArticleMolecular psychiatry2026

SETDB1 modulates neuroinflammation in the mouse cortex by regulating neuronal P2rx7 expression.

Yueyan Zhu, Liyong Liao, Xixi Liu, Huan Sheng, Daijing Sun, Jiaqi Li, Qi Chen, Chenchun Zhang, Shunying Wang, Yuan Zhang and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yueyan Zhu *State Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science, and the Institutes of Brain Science, Fudan University, 200032, Shanghai, China.ORCID http://orcid.org/0009-0008-3835-6308
Liyong Liao *State Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science, and the Institutes of Brain Science, Fudan University, 200032, Shanghai, China.ORCID http://orcid.org/0009-0006-5238-2719
Xixi Liu *State Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science, and the Institutes of Brain Science, Fudan University, 200032, Shanghai, China.
Huan Sheng *State Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science, and the Institutes of Brain Science, Fudan University, 200032, Shanghai, China.
Daijing Sun *State Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science, and the Institutes of Brain Science, Fudan University, 200032, Shanghai, China.
Jiaqi LiState Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science, and the Institutes of Brain Science, Fudan University, 200032, Shanghai, China.
Qi ChenState Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science, and the Institutes of Brain Science, Fudan University, 200032, Shanghai, China.
Chenchun ZhangState Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science, and the Institutes of Brain Science, Fudan University, 200032, Shanghai, China.
Shunying WangHuashan Hospital, Fudan University, 200040, Shanghai, China.
Yuan ZhangState Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science, and the Institutes of Brain Science, Fudan University, 200032, Shanghai, China.
Jie WengState Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science, and the Institutes of Brain Science, Fudan University, 200032, Shanghai, China.
Mengling ZhouState Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science, and the Institutes of Brain Science, Fudan University, 200032, Shanghai, China.
Jianneng YangState Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science, and the Institutes of Brain Science, Fudan University, 200032, Shanghai, China.
Yuhao DongState Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science, and the Institutes of Brain Science, Fudan University, 200032, Shanghai, China.
Wenzhu PengState Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science, and the Institutes of Brain Science, Fudan University, 200032, Shanghai, China.
Yue LiState Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science, and the Institutes of Brain Science, Fudan University, 200032, Shanghai, China. yue_li@fudan.edu.cn.
Yan JiangState Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science, and the Institutes of Brain Science, Fudan University, 200032, Shanghai, China. yan_jiang@fudan.edu.cn.ORCID http://orcid.org/0000-0002-5002-4284

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32170601National Natural Science Foundation of China (National Science Foundation of China) 81971272
6 · The paper itself

Abstract

Neuroinflammation is a pivotal feature of neuropsychiatric conditions, yet the brain-intrinsic epigenetic mechanisms initiating this response are not fully understood. In this study, we show that loss of the histone H3K9me3 methyltransferase SETDB1 in excitatory neurons (Setdb1-CK-cKO) triggers endogenous retrovirus (ERV) activation and neuroinflammation in the mouse cortex. ERV activation occurs in both neurons and astrocytes, leading to the emergence of a distinct reactive astrocyte population with increased expression of inflammatory chemokines and cytokines. Mechanistically, we identify the purinergic receptor gene P2rx7 as a direct target of SETDB1. We characterize a novel enhancer in the P2rx7 first intron that is epigenetically silenced by SETDB1; loss of SETDB1 results in increased chromatin accessibility and aberrant P2rx7 overexpression. This epigenetic regulatory mechanism is conserved between mouse and human. Moreover, genetic ablation of P2rx7 in Setdb1-CK-cKO mice partially reverses ERV activation and inflammatory gene dysregulation, and attenuates synaptic dysfunction. These findings provide new mechanistic insight into the epigenetic regulation of P2X7R signaling in controlling endogenous neuroinflammatory responses in the central nervous system.

Indexed as

Histone-Lysine N-MethyltransferaseNeuroinflammatory DiseasesReceptors, Purinergic P2X7AnimalsAstrocytesCerebral CortexEndogenous RetrovirusesEpigenesis, GeneticHumansInflammationMaleMiceMice, Inbred C57BLMice, KnockoutNeuronsSignal TransductionHistone-Lysine N-MethyltransferaseP2rx7 protein, mouseReceptors, Purinergic P2X7SETDB1 protein, mouse

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.